STOCK TITAN
  1. Home
  2. Financials
  3. RGC
  4. EPS (Diluted)

Regencell Bioscience Holdings Limited (RGC) EPS by Year

RGC

Regencell Bioscience Holdings Limited lost $0.72 per diluted share in fiscal year 2025. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Regencell Bioscience Holdings Limited has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.72
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Jun 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RGC EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2210-KFY2110-KFY2010-KFY1910-K
EPS (Diluted)-$0.72-$0.87+26.9%-$1.19-$0.58-346.2%-$0.13-62.5%-$0.08N/A

RGC EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ4'2420-FQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-K
EPS (Diluted)N/AN/AN/AN/AN/AN/A

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Regencell Bioscience Holdings Limited financials

Frequently Asked Questions

What was Regencell Bioscience Holdings Limited's diluted earnings per share in fiscal year 2025?

Regencell Bioscience Holdings Limited lost $0.72 per diluted share in fiscal year 2025.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Regencell Bioscience Holdings Limited (RGC) reported on that line in every period on record.